MD Anderson Madrid – Hospiten holds an international workshop to discuss the use of HIPEC in advanced ovarian cancer Published on 15/02/2024 The meeting will be attended by the main researchers of the OVHIPEC-1(1) and CHIPOR(2) trials, randomised phase 3 studies assessing the potential efficacy of HIPEC in two specific scenarios of ovarian cancer with peritoneal carcinomatosis.
Palliative surgery in peritoneal carcinomatosis can make a difference of months in the survival of the patient with improved quality of life Published on 29/04/2021 PIPAC, a palliative technique for intraperitoneal administration of chemotherapy, can increase the average survival rate by between 16 and 42 months in patients with peritoneal carcinomatosis